The Mulva Family Foundation has given $25 million to melanoma and prostate cancer research at MD Anderson under the direction of Patrick Hwu, M.D., chair of Melanoma Medical Oncology, and Christopher Logothetis, M.D., chair of Genitourinary Medical Oncology.
"This transformational gift is a reflection of the Mulva family's extraordinary generosity and dedication to advancing the end of two of our most menacing foes - melanoma, the deadliest form of skin cancer and prostate cancer, the second leading cause of cancer deaths in men," says Ronald DePinho, M.D., president of MD Anderson. "We are profoundly grateful for the Mulva Family Foundation's remarkable support of MD Anderson's mission. Together, we will change the statistics and create new hope for patients and their loved ones facing the challenges of cancer."
The gift is part of a $75 million grant that includes $50 million to create the Mulva Clinic for the Neurosciences at the Dell Medical School at The University of Texas at Austin.
In a news release announcing the grant, Miriam and Jim Mulva expressed their
passion and commitment to help MD Anderson - the premier cancer center in the world - treat and ultimately eradicate cancer.
Jim Mulva, chair of the MD Anderson Cancer Center Board of Visitors and a UT Austin graduate, is past chairman and CEO of ConocoPhillips. Miriam Mulva is a graduate of St. Norbert College near Green Bay, Wisconsin. The Mulvas are Texas residents and split their time between Austin and Green Bay.
The Mulva Family Foundation has been a consistent supporter of UT Austin and MD Anderson. Medicine, education, youth and the Catholic Church are its primary initiatives. The family's substantial commitments to the university include $60 million to the McCombs School of Business and the Cockrell School of Engineering and $15 million to help build the new Liberal Arts Building. They have given more than $5.6 million to MD Anderson. The Miriam and Jim Mulva Conference Center at MD Anderson is named in recognition of a $5 million gift to the Miriam and Jim Mulva Fund for Melanoma Research.